The analysis was led by Melkam Andargie Belay of Dilla University, together with colleagues at Dilla University and the University of Gondar, and it exploited a rare and valuable data source: the Ethiopia Population-based HIV Impact Assessment, or EPHIA, a household survey conducted in 2017 and 2018. Because EPHIA combined HIV testing with detailed questionnaires on health service use and household assets, it allowed the researchers to link a woman’s HIV status and screening history to her household wealth, place of residence, education, marital status, and other sociodemographic characteristics. From the survey, the team identified 361 women living with HIV who were between 25 and 49 years old, the age band in which cervical cancer screening is recommended in Ethiopia’s national guidelines.

The headline number is bleak. Only 15.5 percent of the women living with HIV in the sample reported ever having been screened for cervical cancer, with a 95 percent confidence interval running from 11.8 to 20.1 percent. In other words, roughly five out of six women in the highest-risk group for this disease had never undergone a screening test. Women living with HIV are at elevated risk because infection with the human immunodeficiency virus impairs immune control of human papillomavirus, the sexually transmitted agent that causes virtually all cervical cancers. Persistent HPV infection in immunocompromised women progresses more rapidly to precancerous lesions and invasive cancer, which is precisely why global guidelines call for more frequent and earlier screening in this population.

What makes the study distinctive is not simply the low overall uptake but the systematic way the authors dissected the inequality embedded within it. The team used a battery of standard health-equity methods, each capturing a different facet of disparity. They constructed equiplots to display screening rates side by side across wealth quintiles. They drew concentration curves, which plot the cumulative share of screening uptake against the cumulative share of the population ranked by wealth, and they computed the concentration index, a single number that summarizes whether a health service is disproportionately used by the rich or the poor. They supplemented these with the slope index of inequality and the relative index of inequality, regression-based measures that quantify absolute and relative differences across the entire socioeconomic gradient rather than only between extreme groups. All analyses were survey-weighted to account for the complex multistage sampling design of EPHIA, ensuring that the estimates reflect the national population of women living with HIV rather than the idiosyncrasies of the sample.

The results revealed a clear wealth gradient. Screening uptake rose from 9.6 percent among women in the poorest household wealth quintile to 20.4 percent among women in the middle quintile, an absolute difference of 10.8 percentage points. The concentration index came out at 0.077, a positive value indicating that screening was concentrated among women of higher socioeconomic status. The magnitude is modest compared with the extreme inequities documented for some other health services in the region, but the authors emphasize that any pro-rich concentration in a preventive service is troubling, particularly when overall coverage is so low that even the wealthiest quintile falls far short of meaningful population protection. In a setting where screening capacity is limited, the women best positioned to reach clinics are the ones getting through the door.

To move beyond description, the researchers turned to Fairlie decomposition, a statistical technique borrowed from labor economics that partitions a gap in an outcome between groups into the portions attributable to differences in observed characteristics. Applied here to wealth-related inequality in screening, the decomposition produced two dominant findings. Residence accounted for 61.2 percent of the wealth-related inequality, and marital status accounted for 49.3 percent. These figures indicate that the screening gap between richer and poorer women is largely explained by where women live and whether they are married, rather than by wealth itself operating through, say, education or awareness in a more diffuse way. Urban women, who tend to live closer to facilities offering visual inspection with acetic acid or other screening modalities, and married women, who may have greater household support and more frequent contact with reproductive health services, are systematically more likely to be screened.

The technical machinery behind these conclusions deserves attention because it illustrates how modern health-equity research works. The concentration index, bounded between minus one and plus one, doubles the area between the concentration curve and the line of equality; a value of zero would mean screening uptake is distributed identically across the wealth distribution. The slope index of inequality expresses the absolute difference in coverage between the hypothetically richest and poorest individuals after accounting for the ranked position of every group, while the relative index of inequality expresses the same contrast as a ratio. By triangulating these measures, the authors guarded against the possibility that a single statistic might mislead, and by weighting every estimate with the survey’s sampling probabilities they ensured the figures generalize to Ethiopia as a whole. The Fairlie decomposition then converted a descriptive observation, that richer women are screened more often, into an actionable one: the gap tracks residence and marital status, which are modifiable targets for outreach.

The findings land at a consequential moment. The World Health Organization has launched a global strategy to eliminate cervical cancer as a public health problem, built on three pillars: high coverage of HPV vaccination, widespread screening with treatment of precancerous lesions, and access to cancer care. The elimination targets call for screening a large majority of eligible women at least once in the relevant age window, a threshold that Ethiopia’s 15.5 percent uptake among women living with HIV does not approach. Because women living with HIV are explicitly designated a priority group in the WHO framework, the Ethiopian data suggest that the very population the elimination strategy most depends on reaching is being left behind, and left behind unevenly. National policy in Ethiopia likewise directs health services to prioritize HIV-positive women for cervical screening, making the observed gap a matter of policy compliance as much as clinical practice.

The authors argue that closing the gap will require deliberately targeted, equity-focused interventions rather than a uniform expansion of services that would predictably reach the same advantaged groups first. Their decomposition results point to concrete levers. Programs that bring screening to rural communities, through mobile clinics, integration with existing antiretroviral therapy visits, or outreach through community health workers, would directly address the residence-driven component of inequality. Interventions attentive to unmarried women, who may face stigma, reduced household support, or fewer touchpoints with maternal and reproductive health services, would address the marital-status component. Integrating screening into routine HIV care is an especially promising avenue, since women on antiretroviral therapy already maintain regular contact with the health system, and co-locating services removes a major access barrier that falls hardest on the poorest and most remote patients.

There are limits to what a single cross-sectional survey can show. The analysis captures screening uptake at one point in time, cannot establish causal relationships between wealth, residence, marital status and screening, and rests on a sample of 361 women, which, while adequate for the survey-weighted methods employed, limits the precision of subgroup estimates. Self-reported screening may also be subject to recall error. Yet the study’s strengths are considerable: a nationally representative data source, a rigorous suite of inequality metrics, and a decomposition that converts a broad concern about inequity into specific, testable targets for intervention. As the authors conclude, achieving the WHO’s elimination goals and complying with Ethiopia’s own national policy will demand a more purposeful approach, one that places marital status and residence at the center of program design. Further research, they note, should build on these findings to ensure that the promise of cervical cancer elimination extends to every woman living with HIV, not only to those fortunate enough to live near a screening clinic or to have a spouse who encourages the visit.

Subject of Research: Socioeconomic inequalities in cervical cancer screening uptake among women living with HIV in Ethiopia

Article Title: Socioeconomic inequalities in cervical cancer screening uptake among women living with HIV in Ethiopia: findings from the Ethiopian population-based HIV impact assessment survey

Article References: Andargie Belay, M., Tenkolu Bune, G., Melkamu Asaye, M., & Alemu, K. (2026). Socioeconomic inequalities in cervical cancer screening uptake among women living with HIV in Ethiopia: findings from the Ethiopian population-based HIV impact assessment survey. International Journal for Equity in Health. https://doi.org/10.1186/s12939-026-03012-9

Image Credits: AI Generated

DOI: 10.1186/s12939-026-03012-9

Keywords: cervical cancer screening, women living with HIV, socioeconomic inequality, Ethiopia, EPHIA survey, health equity, concentration index, Fairlie decomposition, HPV, WHO elimination strategy, rural-urban disparities, public health

For decades, antiretroviral therapies have transformed HIV from a fatal disease into a manageable chronic condition. Despite these advances, women with HIV in the United States continue to experience an alarming life expectancy deficit of approximately 12 years compared to women without the virus. This discrepancy has prompted scientists to probe deeper into the underlying causes of mortality, with UCSF’s latest study providing the first detailed comparison between death certificate data and clinical insights from health care professionals intimately familiar with the patients’ medical and social histories.

The investigative team evaluated the deaths of 40 women enrolled in UCSF’s Women’s HIV Program who passed away between 2004 and 2023. Inclusion was limited to cases where clinicians—doctors, nurses, social workers, and pharmacists—had direct knowledge of the patients’ multifaceted health conditions. While HIV was officially documented as a cause of death in 68% of these cases on death certificates, the healthcare providers determined that HIV contributed to only 15% of the deaths upon comprehensive review. Instead, mental health disorders and substance abuse emerged as the predominant causes, each implicated in 58% of deaths, starkly contrasting with death certificates listing these factors in just 5% and 13% of instances respectively.

This discrepancy underscores significant limitations in vital statistics records, which often omit critical context surrounding mortality among people living with HIV. The prevailing death record systems tend to attribute mortality primarily to HIV, disregarding the nuanced interplay of trauma-related comorbidities such as depression, addiction, and the psychosocial burdens of stigma and isolation. These conditions, deeply rooted in social determinants of health and historical trauma, play a pivotal role in precipitating fatal outcomes yet remain grossly underreported.

Further illuminating these disparities, suicides were recorded on only 3% of death certificates but were identified by clinicians in 13% of cases. Other contributors—namely cigarette smoking, intimate partner violence, non-adherence to treatment regimens, and pervasive HIV-related stigma—were routinely recognized by care teams but absent from official mortality documentation. These omissions hinder public health efforts by masking the true landscape of risks faced by women living with HIV and perpetuate narrowly focused interventions that do not address the holistic needs of this population.

The implications of these findings are far-reaching. Dr. Edward Machtinger, MD, a senior author and co-director of the Women’s HIV Program at UCSF, emphasizes that combating HIV-related mortality requires health care paradigms grounded in trauma-informed principles. “The relentless focus on viral load suppression, while critical, is insufficient without concurrently addressing the psychological and social adversities that undermine health,” he states. This approach prioritizes integrated care models that engage mental health professionals, addiction specialists, and social services alongside infectious disease treatment.

Co-author Katy Davis, PhD, a social worker and trauma therapist who also co-directs the clinic, underscores the revolution in care strategies catalyzed by this research. “Our entire clinic has shifted to ensure that patients feel safe, validated, and supported as they heal from the layered impacts of past trauma. This trauma-informed model should become the standard of care for individuals living with HIV to enhance longevity and quality of life,” she asserts. Trauma-informed care recognizes the pervasive impact of adverse experiences and creates an empathetic framework that avoids retraumatization and promotes resilience.

While the study centered on women, there is suggestive evidence that men living with HIV suffer similarly reduced life expectancies and comparable trauma-related mortality factors, vitalizing the urgency to broaden research to encompass diverse populations. Furthermore, the relatively small sample size of 40 patients represents an initial but potent indication of systemic issues that likely persist across wider demographics and geographies.

The findings compel a reevaluation of public health policies and clinical guidelines. Instead of treating HIV solely as a virological condition necessitating pharmaceutical intervention, health systems must develop comprehensive strategies that integrate behavioral health, trauma recovery, stigma reduction, and social support. Strategies such as routine mental health screenings, substance use disorder treatment programs, community-based resources, and interventions targeting intimate partner violence could collectively reduce preventable deaths in this vulnerable group.

Moreover, the study accentuates the critical need for improved mortality data collection methods. Developing refined classification frameworks that encapsulate the complex causality associated with deaths among people living with HIV could lead to more accurate surveillance, better resource allocation, and enhanced programmatic responses. This would demand close collaboration between clinical care providers, epidemiologists, and public health authorities to reform reporting systems.

In conclusion, UCSF’s incisive research spotlights a profound gap between clinical realities and official death records, revealing that preventable, trauma-related conditions are the leading causes of death for women living with HIV. This reorientation from a purely biomedical to a biopsychosocial model of care promises to foster more compassionate, effective, and life-extending interventions. As HIV management continues evolving, the integration of trauma-informed health paradigms offers a hopeful horizon for addressing the multi-layered challenges faced by this population.

Subject of Research: Causes of death in women living with HIV, with a focus on trauma-related conditions and discrepancies between death certificates and clinical assessments.

Article Title: Causes of Death of Women with HIV: Discordance Between Death Certificates and Clinical Findings

News Publication Date: June 12, 2026

Web References:

• Journal of Acquired Immune Deficiency Syndromes: https://journals.lww.com/jaids/fulltext/2026/07010/causes_of_death_of_women_with_hiv__discordance.3.aspx
• UCSF Health: https://www.ucsfhealth.org/
• UCSF Main Site: https://www.ucsf.edu/

References:
Machtinger, E., Davis, K., Cuca, Y.P., Shumway, M., Naranjo-Cabatic, E., Cocohoba, J., & Loomba, V. (2026). Causes of Death of Women with HIV: Discordance Between Death Certificates and Clinical Findings. Journal of Acquired Immune Deficiency Syndromes.

Keywords: Human immunodeficiency virus, trauma-informed care, mortality rates, mental health, substance abuse, HIV stigma, suicide, intimate partner violence, treatment non-adherence, chronic stress, depression, tobacco, alcohol abuse.